Experienced and professional traders get richer due to the rise of extremely cheap stocks like GAXY, RLFTF, BANT, ENZC, LKNCY. Today we go through the heroically looking Enzolytics (ENZC) which focuses on the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Shortly, it is a biotech firm that wants to be a leader in treating HIV/AIDS patients.
Interesting moves have been happening to ENZC; from 15 to 21 September the stock steeply grew at least by 800% and from 25 to 29 September it rose 70% minimum. Soon the stock could surge even by 10 folds because of its penny look and promising projects in waking up the immune system of deadly infectious deceases.
Most probably, ENZC will slowly rise by 2% on Monday but any time it can rocket crazily as OTC stocks tend to be furious in growth. Next week could be the worst for the stocks amid rising fear of COVID-19. However, few biotech stocks may conversely jump on trading millions of shares.